Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibody-Drug Conjugates (ADCs)
    (2)
  • ADC Cytotoxin
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

maytansinoid dm4

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
Maytansinoid DM4
T13766799840-96-3
Maytansinoid DM4, a thiol-containing maytansine derivative, is a highly potent cytotoxic moiety utilized in ADC applications.
  • Inquiry Price
6-8 weeks
Size
QTY
Indatuximab ravtansine
nBT062-DM4, BT-062
T9901A-2241238517-16-2
Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) (Antibody-Drug Conjugates (ADCs)) that consists of a murine-human chimeric form based on B-B4, which specifically targets CD138, linked via a disulfide bond to the maytansinoid drug DM4. It exhibits antitumor activity.
  • Inquiry Price
Size
QTY
Tusamitamab ravtansine
SAR-408701, HuMAb2-3-SPDB-DM4
T779072254086-60-5
Tusamitamab ravtansine (SAR-408701) is a DM4-linked anti-CEACAM5 antibody-drug conjugate (ADC) comprising a humanized monoclonal antibody targeting carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) conjugated to a cytotoxic maytansinoid, selectively engaging CEACAM5-positive tumor cells [1].
  • Inquiry Price
Size
QTY
S-Me-DM4
T77872890654-03-2
S-Me-DM4 is an intracellular enzyme S-methylated metabolite of DM4, a maytansinoid with microtubule-depolymerizing properties and potent cytotoxicity, employed as an Antibody-Drug Conjugate (ADC) cytotoxin [1].
  • Inquiry Price
8-10 weeks
Size
QTY